Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 79INDUSTRY 62NIH 7OTHER_GOV 3UNKNOWN 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Lymphoma 27Leukemia 16Lung Neoplasms 13Neuroblastoma 12Burkitt Lymphoma 11Lymphoma, Large B-Cell, Diffuse 10Hodgkin Disease 10Sarcoma 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Central Nervous System Neoplasms 9Brain Neoplasms 9Teratoma 8Carcinoma, Non-Small-Cell Lung 7Wilms Tumor 6Neuroectodermal Tumors, Primitive, Peripheral 6Leukemia, Myeloid, Acute 6Testicular Neoplasms 5Lymphoma, Non-Hodgkin 5Ovarian Neoplasms 4Medulloblastoma 4Lymphoma, Follicular 4Leukemia, Myelomonocytic, Acute 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Endodermal Sinus Tumor 4Dendritic Cell Sarcoma, Interdigitating 4Carcinoma, Embryonal 4Sarcoma, Ewing 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Cisplatin 3Taxes 2Psychiatric Rehabilitation 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Etoposide 2rubitecan 1pembrolizumab 1monalizumab 1marimastat 1etoposide phosphate 1durvalumab 1ceralasertib 1carfilzomib 1atezolizumab 1Watchful Waiting 1Sunitinib 1Specimen Handling 1Radiotherapy, Conformal 1Polymerase Chain Reaction 1Platinum Compounds 1PM 01183 1Nivolumab 1NK Cell Lectin-Like Receptor Subfamily C 1Mental Status and Dementia Tests 1Isotretinoin 1Irinotecan 1Ipilimumab 1Introns 1Interferon-alpha 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Small Cell Lung Carcinoma × Etoposide × Clear all
NCT06769126 2026-03-30

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

SWOG Cancer Research Network

Phase 2 Recruiting
900 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT02580994 2023-12-11

REACTION

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
125 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡